Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
190.9 USD | +0.22% | -3.38% | -26.01% |
03:24pm | Needham Adjusts Price Target on Biogen to $294 From $300 | MT |
02:57pm | BMO Capital Adjusts Price Target on Biogen to $260 From $285, Outperform Rating Kept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.01% | 27.69B | |
-5.99% | 84.46B | |
+3.95% | 40.85B | |
+52.85% | 24.28B | |
-6.67% | 17.09B | |
-32.37% | 13.67B | |
-15.92% | 11.86B | |
-10.45% | 11.79B | |
-3.00% | 8.07B | |
+3.23% | 7.51B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen Posts Flat Q3 Adjusted Earnings, Revenue Decline; Raises FY2022 Guidance